EE9700102A - Selegiliini sisaldav liposoomne kompositsioon - Google Patents

Selegiliini sisaldav liposoomne kompositsioon

Info

Publication number
EE9700102A
EE9700102A EE9700102A EE9700102A EE9700102A EE 9700102 A EE9700102 A EE 9700102A EE 9700102 A EE9700102 A EE 9700102A EE 9700102 A EE9700102 A EE 9700102A EE 9700102 A EE9700102 A EE 9700102A
Authority
EE
Estonia
Prior art keywords
weight
pct
liposomic
composition
selegilin
Prior art date
Application number
EE9700102A
Other languages
English (en)
Other versions
EE03418B1 (et
Inventor
Mezei Michael
Ga�l J�zsef
Sz�k�cs G�bor
Szebeni Gyula
M�rmarosi Tam�sn�
Magyar K�lm�n
Lengyel J�zsef
Szatm�ri Istv�n
T�ri �gnes
Original Assignee
Chinoin Gy�gyszer �s Vegy�szeti Term�kek Gy�ra Rt.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chinoin Gy�gyszer �s Vegy�szeti Term�kek Gy�ra Rt. filed Critical Chinoin Gy�gyszer �s Vegy�szeti Term�kek Gy�ra Rt.
Publication of EE9700102A publication Critical patent/EE9700102A/et
Publication of EE03418B1 publication Critical patent/EE03418B1/et

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Vascular Medicine (AREA)
  • Psychology (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Dental Preparations (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
  • Detergent Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
EE9700102A 1994-10-24 1995-10-20 Selegiliini sisaldav liposoomne kompositsioon EE03418B1 (et)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
HU9403073A HU223475B1 (hu) 1994-10-24 1994-10-24 Selegilint tartalmazó liposzoma-készítmény és eljárás ennek előállítására
PCT/HU1995/000052 WO1996012472A1 (en) 1994-10-24 1995-10-20 Liposome composition containing selegilin

Publications (2)

Publication Number Publication Date
EE9700102A true EE9700102A (et) 1997-10-15
EE03418B1 EE03418B1 (et) 2001-06-15

Family

ID=10985697

Family Applications (1)

Application Number Title Priority Date Filing Date
EE9700102A EE03418B1 (et) 1994-10-24 1995-10-20 Selegiliini sisaldav liposoomne kompositsioon

Country Status (30)

Country Link
US (1) US5888536A (et)
EP (1) EP0788349B1 (et)
JP (1) JPH10507749A (et)
KR (1) KR100313149B1 (et)
CN (1) CN1084186C (et)
AT (1) ATE205387T1 (et)
AU (1) AU691348B2 (et)
BG (1) BG63327B1 (et)
BR (1) BR9509517A (et)
CA (1) CA2203513C (et)
CZ (1) CZ287349B6 (et)
DE (1) DE69522701T2 (et)
DK (1) DK0788349T3 (et)
EE (1) EE03418B1 (et)
ES (1) ES2160718T3 (et)
FI (1) FI971743A0 (et)
HU (1) HU223475B1 (et)
IL (1) IL115754A (et)
NO (1) NO316354B1 (et)
NZ (1) NZ294660A (et)
PL (1) PL183104B1 (et)
PT (1) PT788349E (et)
RO (1) RO116768B1 (et)
RU (1) RU2159106C2 (et)
SK (1) SK281599B6 (et)
TW (1) TW412420B (et)
UA (1) UA44289C2 (et)
WO (1) WO1996012472A1 (et)
YU (1) YU49313B (et)
ZA (1) ZA958999B (et)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2319318A1 (en) * 1998-01-27 1999-07-29 Thomas N. Thomas Methods of treatment using mao-a and mao-b inhibitors such as l-deprenyl
DE19814257A1 (de) 1998-03-31 1999-10-07 Asta Medica Ag Brauseformulierungen
GB9815785D0 (en) * 1998-07-20 1998-09-16 Cerebrus Ltd Chemical compounds
WO2005053605A2 (en) * 2003-09-09 2005-06-16 Gilead Sciences, Inc. Therapeutic liposomes
US20080233053A1 (en) * 2005-02-07 2008-09-25 Pharmalight Inc. Method and Device for Ophthalmic Administration of Active Pharmaceutical Ingredients
CN1813679A (zh) * 2005-11-30 2006-08-09 上海医药(集团)有限公司 一种紫杉烷脂质体冻干组合物及其制备方法
US9445975B2 (en) 2008-10-03 2016-09-20 Access Business Group International, Llc Composition and method for preparing stable unilamellar liposomal suspension
JP5623102B2 (ja) * 2010-03-12 2014-11-12 株式会社フジモト・コーポレーション セレギリン含有貼付製剤
JP5693026B2 (ja) * 2010-03-12 2015-04-01 株式会社フジモト・コーポレーション セレギリン含有貼付製剤
US9668974B2 (en) 2012-05-10 2017-06-06 Painreform Ltd. Depot formulations of a local anesthetic and methods for preparation thereof
AU2015326378B2 (en) * 2014-09-29 2021-01-21 Council Of Scientific & Industrial Research A formulation useful for delivery of neuro protecting agent
LT3600435T (lt) * 2017-03-23 2024-04-25 Lipid Systems Sp. Z.O.O. Hidrofilinių junginių aukšto efektyvumo įkapsuliavimas vienasluoksnėse liposomose

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH588887A5 (et) * 1974-07-19 1977-06-15 Battelle Memorial Institute
US4485054A (en) * 1982-10-04 1984-11-27 Lipoderm Pharmaceuticals Limited Method of encapsulating biologically active materials in multilamellar lipid vesicles (MLV)
US4761288A (en) * 1984-09-24 1988-08-02 Mezei Associates Limited Multiphase liposomal drug delivery system
GB8807504D0 (en) * 1988-03-29 1988-05-05 Sandoz Ltd Improvements in/relating to organic compounds
US4937078A (en) * 1988-08-26 1990-06-26 Mezei Associates Limited Liposomal local anesthetic and analgesic products
FR2713087B1 (fr) * 1993-11-30 1996-02-23 Saurat Jean Hilaire Utilisation de la sélégiline et ses dérivés pour la préparation d'un médicament destiné au traitement du psoriasis.

Also Published As

Publication number Publication date
MX9703019A (es) 1997-10-31
NO971870D0 (no) 1997-04-23
HUT76053A (en) 1997-06-30
YU67195A (sh) 1998-07-10
FI971743A (fi) 1997-04-23
EE03418B1 (et) 2001-06-15
PT788349E (pt) 2001-12-28
EP0788349A1 (en) 1997-08-13
BG101432A (en) 1997-12-30
FI971743A0 (fi) 1997-04-23
AU691348B2 (en) 1998-05-14
CZ287349B6 (en) 2000-10-11
CN1163563A (zh) 1997-10-29
ATE205387T1 (de) 2001-09-15
PL319875A1 (en) 1997-09-01
AU3751895A (en) 1996-05-15
DE69522701T2 (de) 2002-07-11
UA44289C2 (uk) 2002-02-15
BG63327B1 (bg) 2001-10-31
CA2203513C (en) 2001-10-09
DE69522701D1 (de) 2001-10-18
HU223475B1 (hu) 2004-07-28
CN1084186C (zh) 2002-05-08
BR9509517A (pt) 1997-12-30
TW412420B (en) 2000-11-21
HU9403073D0 (en) 1994-12-28
US5888536A (en) 1999-03-30
NO971870L (no) 1997-06-24
DK0788349T3 (da) 2001-11-26
CZ114797A3 (en) 1997-10-15
SK281599B6 (sk) 2001-05-10
KR100313149B1 (ko) 2002-02-19
WO1996012472A1 (en) 1996-05-02
JPH10507749A (ja) 1998-07-28
NO316354B1 (no) 2004-01-19
CA2203513A1 (en) 1996-05-02
RO116768B1 (ro) 2001-06-29
KR970706797A (ko) 1997-12-01
RU2159106C2 (ru) 2000-11-20
EP0788349B1 (en) 2001-09-12
PL183104B1 (pl) 2002-05-31
NZ294660A (en) 1998-05-27
IL115754A0 (en) 1996-01-19
IL115754A (en) 1999-07-14
SK51797A3 (en) 1997-11-05
YU49313B (sh) 2005-06-10
ES2160718T3 (es) 2001-11-16
ZA958999B (en) 1996-05-15

Similar Documents

Publication Publication Date Title
ES2301189T3 (es) Agentes de limpieza antimicrobianos.
NO974023L (no) Topisk appliserbart farmasöytisk preparat, fremgangsmåte for dets fremstilling og anvendelse derav
JP5616620B2 (ja) 非イオン性シリコーンハイドロゲルコンタクトレンズ用眼科組成物
EE9700102A (et) Selegiliini sisaldav liposoomne kompositsioon
JP2002003364A (ja) 点眼剤、眼科用組成物及び吸着抑制方法
JP3142842B1 (ja) 眼科用組成物及びソフトコンタクトレンズへの吸着抑制方法
JP2018188486A (ja) 非イオン性シリコーンハイドロゲルコンタクトレンズ用点眼剤
JP3175742B1 (ja) コンタクトレンズ用眼科用組成物
JP5681472B2 (ja) 眼科用組成物
TR200100897T2 (tr) Lipid metabolizma bozukluklarının tedavisinde safra asitleriyle bağlı propanolamin türevleri.
JP2011111441A (ja) 非イオン性シリコーンハイドロゲルコンタクトレンズ用眼科組成物
JP5650864B2 (ja) 非イオン性シリコーンハイドロゲルコンタクトレンズ用眼科組成物
JP2005075735A (ja) オキシメタゾリン含有組成物
JP2002104971A (ja) 眼科用組成物
JP2002338476A (ja) 腎透析に伴う痒みの予防治療剤
JPH11180872A (ja) 骨代謝改善剤
JPH1129461A (ja) ヒドロキシアスパラギン酸を含有する皮膚外用剤

Legal Events

Date Code Title Description
KB4A Valid patent at the end of a year

Effective date: 20021231

KB4A Valid patent at the end of a year

Effective date: 20031231

KB4A Valid patent at the end of a year

Effective date: 20041231

KB4A Valid patent at the end of a year

Effective date: 20051231

KB4A Valid patent at the end of a year

Effective date: 20061231

KB4A Valid patent at the end of a year

Effective date: 20071231

MM4A Lapsed by not paying the annual fees

Effective date: 20071020